Are We Exposing Patients with a Mildly Elevated Faecal Calprotectin to Unnecessary Investigations?

BÜHLMANN fCAL® ELISA Citation

Seenan, JP,Thomson, Rankin K, Smith K, Gaya DR.  Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations? Gastroenterology.  2014 Frontline Gastroenterol doi:10.1136/flgastro-2014-100467.

Highlight from this Publication

“…we propose an alternative diagnostic approach of repeating the FC after 6-8 weeks in patients with values of 100-200 µg/g.”

Read Citation

BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use.

Health Canada License: 80726